Compare LECO & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LECO | HOLX |
|---|---|---|
| Founded | 1895 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 16.6B |
| IPO Year | N/A | 1990 |
| Metric | LECO | HOLX |
|---|---|---|
| Price | $245.33 | $74.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 15 |
| Target Price | ★ $244.00 | $79.64 |
| AVG Volume (30 Days) | 368.9K | ★ 3.0M |
| Earning Date | 10-30-2025 | 11-03-2025 |
| Dividend Yield | ★ 1.29% | N/A |
| EPS Growth | ★ 11.30 | N/A |
| EPS | ★ 9.34 | 2.49 |
| Revenue | ★ $4,176,319,000.00 | $4,100,500,000.00 |
| Revenue This Year | $7.92 | $6.69 |
| Revenue Next Year | $6.01 | $5.74 |
| P/E Ratio | ★ $26.28 | $30.11 |
| Revenue Growth | ★ 3.24 | 1.74 |
| 52 Week Low | $161.11 | $51.90 |
| 52 Week High | $249.19 | $80.31 |
| Indicator | LECO | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 65.20 | 67.93 |
| Support Level | $234.05 | $74.55 |
| Resistance Level | $242.17 | $75.12 |
| Average True Range (ATR) | 5.38 | 0.28 |
| MACD | 2.01 | -0.14 |
| Stochastic Oscillator | 95.32 | 78.92 |
Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. Its portfolio includes arc-welding solutions, plasma and oxy-fuel cutting systems, brazing and soldering alloys, and automation solutions. Lincoln Electric serves clients across general fabrication, heavy industries, automotive, construction, shipbuilding, energy, and process industries, among others. Based in Cleveland, Lincoln Electric operates in 19 countries and employs 11,000 worldwide. The company generated roughly $4 billion in sales in 2024.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.